Caliway intends to commence both pivotal Phase III trials soon, with clinical results for CBL-0301 and CBL-0302 expected in ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Injections deliver liquid medications, fluids, or nutrients directly into a person’s body. Different types of injections include intravenous, intramuscular, subcutaneous, intraosseous, and intradermal ...

FDA approved pembrolizumab and berahyaluronidase alfa-pmph for patients aged 12 and older with solid tumors. Study MK-3475A-D77 showed a 45% ORR in subcutaneous administration for treatment-naïve ...

Results of SUBCUT HF II, the first full-scale outcomes trial of subcutaneous furosemide for at-home treatment of edema in heart failure patients, to be released on May 9th at international heart ...